<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: Copeland Capital Management, LLC -->
          <cik>0001541743</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>12/31/2024</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001158895</issuerCik>
        <issuerName>LEMAITRE VASCULAR INC</issuerName>
        <issuerCusip>525558201</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>63 Second Avenue</com:street1>
          <com:city>Burlington</com:city>
          <com:stateOrCountry>MA</com:stateOrCountry>
          <com:zipCode>01803</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(b)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Copeland Capital Management</reportingPersonName>
      <citizenshipOrOrganization>DE</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>803212.00</soleVotingPower>
        <sharedVotingPower>185768.00</sharedVotingPower>
        <soleDispositivePower>803212.00</soleDispositivePower>
        <sharedDispositivePower>185768.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>988980.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>5.21</classPercent>
      <typeOfReportingPerson>IA</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>LEMAITRE VASCULAR INC</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>63 Second Avenue Burlington, Massachusetts 01803</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>Sofia A. Rosala</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>161 Washington St, Suite 1325, Conshohocken, PA 19428</principalBusinessOfficeOrResidenceAddress>
        <citizenship>U.S.A</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>N</notApplicableFlag>
        <typeOfPersonFiling>IA</typeOfPersonFiling>
      </item3>
      <item4>
        <amountBeneficiallyOwned>5.21%</amountBeneficiallyOwned>
        <classPercent>5.21%</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>803,212</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>185,768</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>803,212</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>185,678</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the foreign regulatory scheme applicable to Sofia A. Rosala is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution(s). I also undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D.</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Copeland Capital Management</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Sofia A. Rosala</signature>
        <title>General Counsel and CCO</title>
        <date>01/24/2025</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>